Revvity ROA 2011-2025 | RVTY
Current and historical return on assets (ROA) values for Revvity (RVTY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Revvity ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.24B | $12.14B | 1.93% |
| 2025-06-30 | $0.29B | $12.36B | 2.29% |
| 2025-03-31 | $0.29B | $12.36B | 2.25% |
| 2024-12-31 | $0.27B | $12.39B | 2.08% |
| 2024-09-30 | $0.25B | $12.77B | 1.91% |
| 2024-06-30 | $0.17B | $13.43B | 1.26% |
| 2024-03-31 | $0.15B | $13.43B | 1.10% |
| 2023-12-31 | $0.69B | $13.57B | 4.96% |
| 2023-09-30 | $0.74B | $13.42B | 5.26% |
| 2023-06-30 | $0.82B | $14.22B | 5.76% |
| 2023-03-31 | $0.96B | $14.64B | 6.77% |
| 2022-12-31 | $0.57B | $14.13B | 3.99% |
| 2022-09-30 | $0.63B | $13.82B | 4.36% |
| 2022-06-30 | $0.67B | $14.19B | 4.57% |
| 2022-03-31 | $0.74B | $14.85B | 5.54% |
| 2021-12-31 | $0.94B | $15.00B | 7.96% |
| 2021-09-30 | $1.13B | $14.90B | 11.23% |
| 2021-06-30 | $1.18B | $8.74B | 14.63% |
| 2021-03-31 | $1.07B | $8.76B | 14.20% |
| 2020-12-31 | $0.73B | $7.96B | 10.46% |
| 2020-09-30 | $0.41B | $6.87B | 6.25% |
| 2020-06-30 | $0.30B | $6.64B | 4.53% |
| 2020-03-31 | $0.23B | $6.38B | 3.52% |
| 2019-12-31 | $0.23B | $6.54B | 3.57% |
| 2019-09-30 | $0.23B | $6.49B | 3.75% |
| 2019-06-30 | $0.25B | $6.40B | 4.14% |
| 2019-03-31 | $0.25B | $6.09B | 4.14% |
| 2018-12-31 | $0.24B | $5.98B | 3.98% |
| 2018-09-30 | $0.13B | $5.86B | 2.10% |
| 2018-06-30 | $0.14B | $5.96B | 2.44% |
| 2018-03-31 | $0.28B | $6.13B | 5.19% |
| 2017-12-31 | $0.29B | $6.09B | 5.93% |
| 2017-09-30 | $0.40B | $4.74B | 8.89% |
| 2017-06-30 | $0.37B | $4.61B | 8.35% |
| 2017-03-31 | $0.23B | $4.34B | 5.28% |
| 2016-12-31 | $0.23B | $4.28B | 5.51% |
| 2016-09-30 | $0.24B | $4.31B | 5.62% |
| 2016-06-30 | $0.23B | $4.19B | 5.64% |
| 2016-03-31 | $0.22B | $4.21B | 5.31% |
| 2015-12-31 | $0.21B | $4.17B | 5.20% |
| 2015-09-30 | $0.18B | $4.03B | 4.30% |
| 2015-06-30 | $0.16B | $4.08B | 4.02% |
| 2015-03-31 | $0.16B | $4.03B | 4.08% |
| 2014-12-31 | $0.16B | $4.13B | 3.94% |
| 2014-09-30 | $0.19B | $3.89B | 4.90% |
| 2014-06-30 | $0.19B | $3.94B | 4.86% |
| 2014-03-31 | $0.17B | $3.97B | 4.34% |
| 2013-12-31 | $0.17B | $3.95B | 4.33% |
| 2013-09-30 | $0.08B | $3.85B | 2.19% |
| 2013-06-30 | $0.07B | $3.81B | 1.92% |
| 2013-03-31 | $0.08B | $3.81B | 2.08% |
| 2012-12-31 | $0.07B | $3.90B | 1.84% |
| 2012-09-30 | $0.00B | $3.89B | 0.08% |
| 2012-06-30 | $0.01B | $3.80B | 0.27% |
| 2012-03-31 | $0.01B | $3.86B | 0.16% |
| 2011-12-31 | $0.01B | $3.86B | 0.23% |
| 2011-09-30 | $0.39B | $3.40B | 11.49% |
| 2011-06-30 | $0.36B | $3.60B | 10.90% |
| 2011-03-31 | $0.39B | $3.31B | 12.15% |
| 2010-12-31 | $0.39B | $3.21B | 12.38% |
| 2010-09-30 | $0.13B | $3.25B | 4.20% |
| 2010-06-30 | $0.13B | $3.15B | 4.30% |
| 2010-03-31 | $0.10B | $3.03B | 3.18% |
| 2009-12-31 | $0.08B | $3.06B | 2.78% |
| 2009-09-30 | $0.08B | $3.06B | 2.65% |
| 2009-06-30 | $0.12B | $2.95B | 3.95% |
| 2009-03-31 | $0.12B | $2.86B | 3.97% |
| 2008-12-31 | $0.13B | $2.93B | 4.20% |
| 2008-09-30 | $0.15B | $3.02B | 4.92% |
| 2008-06-30 | $0.13B | $3.08B | 4.38% |
| 2008-03-31 | $0.14B | $3.08B | 4.95% |
| 2007-12-31 | $0.13B | $2.95B | 5.03% |
| 2007-09-30 | $0.12B | $2.59B | 4.82% |
| 2007-06-30 | $0.12B | $2.53B | 4.82% |
| 2007-03-31 | $0.11B | $2.50B | 4.42% |
| 2006-12-31 | $0.12B | $2.51B | 4.78% |
| 2006-09-30 | $0.27B | $2.50B | 10.40% |
| 2006-06-30 | $0.27B | $2.54B | 10.49% |
| 2006-03-31 | $0.27B | $2.50B | 10.73% |
| 2005-12-31 | $0.27B | $2.69B | 10.50% |
| 2005-09-30 | $0.12B | $2.49B | 4.70% |
| 2005-06-30 | $0.11B | $2.49B | 4.36% |
| 2005-03-31 | $0.10B | $2.57B | 4.02% |
| 2004-12-31 | $0.10B | $2.58B | 3.75% |
| 2004-09-30 | $0.09B | $2.56B | 3.35% |
| 2004-06-30 | $0.08B | $2.55B | 2.95% |
| 2004-03-31 | $0.06B | $2.56B | 2.39% |
| 2003-12-31 | $0.05B | $2.61B | 1.94% |
| 2003-09-30 | $0.02B | $2.59B | 0.77% |
| 2003-06-30 | $0.01B | $2.78B | 0.51% |
| 2003-03-31 | $0.00B | $2.75B | -0.11% |
| 2002-12-31 | $-0.15B | $2.83B | -5.51% |
| 2002-09-30 | $-0.20B | $2.60B | -7.12% |
| 2002-06-30 | $-0.18B | $2.71B | -6.46% |
| 2002-03-31 | $-0.14B | $2.89B | -5.27% |
| 2001-12-31 | $0.03B | $2.97B | 1.35% |
| 2001-09-30 | $0.12B | $2.27B | 5.46% |
| 2001-06-30 | $0.09B | $2.27B | 4.18% |
| 2001-03-31 | $0.10B | $2.28B | 4.74% |
| 2000-12-31 | $0.09B | $2.19B | 4.71% |
| 2000-09-30 | $0.09B | $2.26B | 4.63% |
| 2000-06-30 | $0.19B | $1.79B | 10.86% |
| 2000-03-31 | $0.16B | $1.75B | 9.20% |
| 1999-12-31 | $0.15B | $1.72B | 9.94% |
| 1999-09-30 | $0.14B | $1.67B | 9.95% |
| 1999-06-30 | $0.05B | $1.65B | 4.30% |
| 1999-03-31 | $0.08B | $1.17B | 7.71% |
| 1998-12-31 | $0.10B | $1.19B | 10.37% |
| 1998-09-30 | $0.10B | $0.92B | 11.51% |
| 1998-06-30 | $0.10B | $0.93B | 11.90% |
| 1998-03-31 | $0.06B | $0.86B | 6.99% |
| 1997-12-31 | $0.03B | $0.83B | 4.17% |
| 1997-09-30 | $0.03B | $0.81B | 3.56% |
| 1997-06-30 | $0.03B | $0.82B | 3.65% |
| 1997-03-31 | $0.06B | $0.81B | 7.02% |
| 1996-12-31 | $0.06B | $0.82B | 7.34% |
| 1996-09-30 | $0.07B | $0.84B | 8.11% |
| 1996-06-30 | $0.07B | $0.84B | 8.24% |
| 1996-03-31 | $0.07B | $0.83B | 8.36% |
| 1995-12-31 | $0.07B | $0.80B | 8.53% |
| 1995-09-30 | $0.06B | $0.79B | 7.30% |
| 1995-06-30 | $-0.01B | $0.79B | -0.76% |
| 1995-03-31 | $-0.01B | $0.81B | -0.75% |
| 1994-12-31 | $-0.01B | $0.79B | -0.76% |
| 1994-09-30 | $0.01B | $0.79B | 0.77% |
| 1994-06-30 | $0.07B | $0.80B | 8.85% |
| 1994-03-31 | $0.07B | $0.77B | 9.46% |
| 1993-12-31 | $0.06B | $0.77B | 7.59% |
| 1993-09-30 | $0.06B | $0.78B | 7.89% |
| 1993-06-30 | $0.07B | $0.81B | 8.90% |
| 1993-03-31 | $0.07B | $0.75B | 9.18% |
| 1992-12-31 | $0.09B | $0.75B | 11.84% |
| 1992-09-30 | $0.09B | $0.75B | 11.78% |
| 1992-06-30 | $0.09B | $0.75B | 12.08% |
| 1992-03-31 | $0.08B | $0.72B | 12.23% |
| 1991-12-31 | $0.08B | $0.70B | 12.14% |
| 1991-09-30 | $0.08B | $0.67B | 11.80% |
| 1991-06-30 | $0.08B | $0.65B | 11.26% |
| 1991-03-31 | $0.08B | $0.68B | 11.30% |
| 1990-12-31 | $0.07B | $0.68B | 11.32% |
| 1990-09-30 | $0.07B | $0.66B | 11.15% |
| 1990-06-30 | $0.07B | $0.64B | 11.33% |
| 1990-03-31 | $0.07B | $0.64B | 11.34% |
| 1989-12-31 | $0.07B | $0.64B | 12.09% |
| 1989-09-30 | $0.07B | $0.55B | 13.41% |
| 1989-06-30 | $0.07B | $0.54B | 13.31% |
| 1989-03-31 | $0.07B | $0.56B | 13.58% |
| 1988-12-31 | $0.07B | $0.54B | 13.22% |
| 1988-09-30 | $0.06B | $0.50B | 11.87% |
| 1988-06-30 | $0.06B | $0.52B | 11.98% |
| 1988-03-31 | $0.06B | $0.52B | 11.60% |
| 1987-12-31 | $0.06B | $0.54B | 11.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.513B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.252B | 28.69 |
| HCA Healthcare (HCA) | United States | $107.856B | 17.86 |
| CVS Health (CVS) | United States | $98.775B | 11.36 |
| Elevance Health (ELV) | United States | $72.412B | 10.62 |
| Cencora (COR) | United States | $70.172B | 22.64 |
| Natera (NTRA) | United States | $28.194B | 0.00 |
| DiDi Global (DIDIY) | China | $24.803B | 20.27 |
| Labcorp Holdings (LH) | United States | $22.125B | 16.87 |
| Medpace Holdings (MEDP) | United States | $16.622B | 41.27 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.514B | 0.00 |
| Solventum (SOLV) | United States | $13.123B | 12.74 |
| ICON (ICLR) | Ireland | $13.097B | 13.00 |
| Viatris (VTRS) | United States | $12.347B | 4.60 |
| CochLear (CHEOY) | Australia | $11.709B | 0.00 |
| HealthEquity (HQY) | United States | $8.768B | 35.09 |
| Charles River Laboratories (CRL) | United States | $8.259B | 15.91 |
| Avantor (AVTR) | United States | $7.759B | 11.85 |
| Sonic Healthcare (SKHHY) | Australia | $6.885B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.729B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.771B | 34.41 |
| Bausch + Lomb (BLCO) | Canada | $5.525B | 36.28 |
| Sotera Health (SHC) | United States | $4.443B | 21.42 |
| GeneDx Holdings (WGS) | United States | $3.702B | 65.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.306B | 0.00 |
| Concentras Parent (CON) | United States | $2.489B | 15.54 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.117B | 41.61 |
| Pediatrix Medical (MD) | United States | $1.988B | 11.87 |
| Surgery Partners (SGRY) | United States | $1.976B | 25.47 |
| Organon (OGN) | United States | $1.958B | 2.06 |
| Establishment Labs Holdings (ESTA) | $1.859B | 0.00 | |
| PACS (PACS) | United States | $1.612B | 0.00 |
| Ardent Health (ARDT) | United States | $1.289B | 4.21 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Omada Health (OMDA) | $1.161B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.008B | 16.50 |
| Embecta (EMBC) | United States | $0.851B | 4.98 |
| CareDx (CDNA) | United States | $0.820B | 13.39 |
| InnovAge Holding (INNV) | United States | $0.657B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.610B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| Nutex Health (NUTX) | United States | $0.595B | 9.01 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.434B | 0.00 |
| Enhabit (EHAB) | United States | $0.409B | 18.39 |
| Strata Critical Medical (SRTA) | United States | $0.391B | 0.00 |
| Pomdoctor - (POM) | China | $0.386B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.383B | 5.76 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| So-Young (SY) | China | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.344B | 6.25 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| KindlyMD (NAKA) | United States | $0.270B | 0.00 |
| Agilon Health (AGL) | United States | $0.239B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 33.37 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 7.21 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |